Clinical Messaging Is Costly but Worth It, Says Vanderbilt Study


Author: Neil Versel
ORLANDO, Fla. — Clinical messaging between providers could cost the U.S. health care system tens of millions of dollars annually, but probably also saves unknown millions just by streamlining coordination of care for the 16 million Americans diagnosed with diabetes, according to a study presented here Monday.

An informatics team at Vanderbilt University Medical Center (Nashville, Tenn.) based this conclusion on research they did in their own disease management program for adults with both diabetes and high cholesterol. They unveiled the findings at an international symposium on improving quality and value in health care, a prelude to the Institute for Healthcare Improvement’s 19th annual forum on health care quality.

In a study of more than 20,000 electronic messages exchanged among 578 physicians and staff during a seven-month period in 2003, Vanderbilt researchers found that each message averaged 26.5 words, took 1.39 minutes to compose and cost the institution 55 cents in labor, based on 2003 dollars. That, they surmise, is far less than the expense generated by transmitting similar information by telephone, fax, and paper, but they left quantifying that element for future study.

“How much is this black box costing us?” is the question they tried to answer since clinical messaging may become a standard of care, according to Steven Deppen, health system database analyst at Vanderbilt. “If this is going to become a method in the future, what’s your methodology for determining the cost of this?”

The research team, which includes biomedical informatics gurus Randall Miller, M.D., from Vanderbilt and Theodore Speroff from the Veterans Affairs Tennessee Valley Healthcare System, also headquartered in Nashville, compared the time it takes to create a handwritten message, and compared it to existing data — from outside of health care — on the average time it takes to write a new e-mail.

Nurses generated 50 percent of the $11,441 in labor costs for messages studied, while physicians, whose messages tended to be shorter but whose time is more expensive, accounted for 37 percent.

The poster presented here follows on work published in the December issue of the journal Medical Care, in which the same group analyzed the content of electronic messaging. In that study, the researchers categorized messages into two broad groups: coordination of care (communication, scheduling, or insurance questions) and production of care (diagnosis, documentation, medication, and treatment). About 62 percent of the messages were related to production, they found.

The research will continue, with the team next attempting to determine if the coordination and timing of messages are optimal, and also to validate the cost model in a general care setting and how cost varies by type of provider. “My guess is this will be very different,” Deppen says.

Some future research will look at how to manage clinical messages within the context of an electronic medical record. “What is the mix of resources if you want to have an electronic component?” wonders Deppen.

Vanderbilt has a well-developed EMR, and much of the school’s in-house work has been commercialized as McKesson’s Horizon Clinicals. The messaging system is self-developed.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.